This EU Industry Week 2021 virtual event will focus on the theme of the European Green Deal and consider the questions Are we ready? and What are the main IP challenges for the... read more →
News
EU-Japan Technology Transfer Helpdesk / Category: News
Time & Location Mar 17, 6:00 PM GMT+9 Online Event About the Event ----- ONLINE EVENT Join us for a... read more →
Date and Time: 10:00 a.m. (CET), on Thursday, March 4, 2021 Under the new initiative between the EU-Japan Technology Transfer Helpdesk and SHIGA, this is the first webinar to introduce... read more →
In spite of COVID-19, the global Space industry experienced significant advances in 2020, likely to further develop into 2021. In 2020 Japan’s National Space Policy Secretariat revised its basic plan... read more →
The recent announcement of Prime Minister Suga of the new Japan engagement towards zero emissions within 2050 has opened an intense discussion within the country about how to achieve this... read more →
Johnson & Johnson, a global pharmaceutical company with cutting-edge capabilities in drug development and a history of successful academic collaborations wishes to identify druggable targets in Chronic Kidney Disease and... read more →
Johnson & Johnson, a global pharmaceutical company with cutting-edge capabilities in drug development and a history of successful academic collaborations, wishes to identify druggable targets in progressive fibrosing interstitial lung... read more →
A multinational biopharmaceutical company with long-standing presence in rheumatology and more recently, immuno-dermatology and bone disorders, are interested in the musculoskeletal area by exploring further indications in this space.
A global biotechnology company interested in both small-molecule and biologics platforms demonstrating therapeutics activity in the field of oncology is seeking Technologies, Research Projects, Spinout Companies and Engagement with Academic... read more →
Italy-Japan approaches for tackling the Covid-19 pandemic: an update on novel vaccines and therapies
The resurgence of the SARS-Cov-2 infections makes even more urgent the quest for vaccines and therapies. After less than one year from the outbreak of the Covid-19 pandemic, almost 700... read more →
